» Articles » PMID: 39822712

Manifestations of Human Atherosclerosis Across Vascular Beds

Overview
Date 2025 Jan 17
PMID 39822712
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Atherosclerosis underlies the most common etiologies of mortality worldwide, resulting in nearly 10 million deaths annually. In atherosclerosis, inflammation, metabolic factors, and hemodynamics cause the accumulation of extracellular lipids and the formation of plaques in the tunica intima of specific arteries. Atherosclerotic plaques primarily form in the coronary and carotid arteries, the aorta, and the peripheral arteries of the lower extremities. Although a common conceptual model of atherogenesis across these arteries has evolved over decades, there is a limited understanding of the important differences in regional atherosclerotic disease.

Methods: This review summarizes clinical studies, meta-analyses, and case reports to compare and contrast the impact, risk, plaque features, and clinical management of carotid, coronary, and femoral atherosclerosis in humans.

Results: Common risk factors, such as smoking and diabetes, influence disease risk differently across vascular beds. In addition, biological variables demonstrate a region-specific relationship with disease as peripheral atherosclerosis is most heritable, and male sex increases the risk of coronary and carotid, but not peripheral artery disease. The pathology of atherosclerotic lesions also varies between vascular territories. Specifically, carotid plaques are primarily lipid rich, whereas coronary plaques more commonly include fibrotic components with lipid-rich features, and femoral plaques are predominantly fibrocalcific. Clinically, interventional outcomes are worst in the carotid arteries and response to medical therapies, particularly statins, is not consistent across diseased regions, even within individual patients.

Conclusions: Atherosclerosis manifests in site-specific ways with regional differences in susceptibility and treatment response. Despite advances in the scientific understanding and clinical management of atherosclerosis, little is known about the mechanisms determining vessel-specific disease patterns and risk. Further research is needed urgently to delineate factors controlling plaque initiation and progression specific to vascular beds.

Citing Articles

The RNA-binding protein RBPMS inhibits smooth muscle cell-driven vascular remodeling in atherosclerosis and vascular injury.

Du J, Yuan X, Wang J, Zhang L, Tan F, Hu T Proc Natl Acad Sci U S A. 2025; 122(9):e2415933122.

PMID: 39999164 PMC: 11892686. DOI: 10.1073/pnas.2415933122.

References
1.
Song P, Fang Z, Wang H, Cai Y, Rahimi K, Zhu Y . Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health. 2020; 8(5):e721-e729. DOI: 10.1016/S2214-109X(20)30117-0. View

2.
Hogberg D, Bjorck M, Mani K, Svensjo S, Wanhainen A . Five Year Outcomes in Men Screened for Carotid Artery Stenosis at 65 Years of Age: A Population Based Cohort Study. Eur J Vasc Endovasc Surg. 2019; 57(6):759-766. DOI: 10.1016/j.ejvs.2019.02.005. View

3.
Derksen W, de Vries J, Vink A, Velema E, Vos J, de Kleijn D . Histologic atherosclerotic plaque characteristics are associated with restenosis rates after endarterectomy of the common and superficial femoral arteries. J Vasc Surg. 2010; 52(3):592-9. DOI: 10.1016/j.jvs.2010.03.063. View

4.
Khaleghi M, Isseh I, Jouni H, Sohn S, Bailey K, Kullo I . Family history as a risk factor for carotid artery stenosis. Stroke. 2014; 45(8):2252-6. DOI: 10.1161/STROKEAHA.114.006245. View

5.
Dake M, Ansel G, Jaff M, Ohki T, Saxon R, Smouse H . Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation. 2016; 133(15):1472-83. PMC: 4823823. DOI: 10.1161/CIRCULATIONAHA.115.016900. View